By Scientia Professor Carla Treloar

Journal articles

Schroeder SE; Drysdale K; Lafferty L; Baldry E; Marshall AD; Higgs P; Dietze P; Stoove M; Treloar C, 2022, '"It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success', International Journal of Drug Policy, 101, pp. 103571, http://dx.doi.org/10.1016/j.drugpo.2021.103571

Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR, 2022, '“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103456

Brener L; Cama E; Broady T; Hopwood M; Treloar C, 2022, 'Comparing Australian health worker and student attitudes and concerns about providing care to people living with hepatitis B', Health Promotion Journal of Australia, 33, pp. 282 - 288, http://dx.doi.org/10.1002/hpja.475

Jin D; Treloar C; Brener L, 2022, 'Hepatitis B virus related stigma among Chinese living in mainland China: a scoping review', Psychology, Health and Medicine, 27, pp. 1760 - 1773, http://dx.doi.org/10.1080/13548506.2021.1944651

Farrugia A; Treloar C; Fraser S, 2022, 'Overdoselifesavers.org: a mixed-method evaluation of a public information website on experiences of overdose and using take-home naloxone to save lives', Drugs: Education, Prevention and Policy, 29, pp. 43 - 53, http://dx.doi.org/10.1080/09687637.2020.1858758

Karlsen TH; Sheron N; Zelber-Sagi S; Carrieri P; Dusheiko G; Bugianesi E; Pryke R; Hutchinson SJ; Sangro B; Martin NK; Cecchini M; Dirac MA; Belloni A; Serra-Burriel M; Ponsioen CY; Sheena B; Lerouge A; Devaux M; Scott N; Hellard M; Verkade HJ; Sturm E; Marchesini G; Yki-Järvinen H; Byrne CD; Targher G; Tur-Sinai A; Barrett D; Ninburg M; Reic T; Taylor A; Rhodes T; Treloar C; Petersen C; Schramm C; Flisiak R; Simonova MY; Pares A; Johnson P; Cucchetti A; Graupera I; Lionis C; Pose E; Fabrellas N; Ma AT; Mendive JM; Mazzaferro V; Rutter H; Cortez-Pinto H; Kelly D; Burton R; Lazarus JV; Ginès P; Buti M; Newsome PN; Burra P; Manns MP, 2022, 'The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality', The Lancet, 399, pp. 61 - 116, http://dx.doi.org/10.1016/S0140-6736(21)01701-3

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J; ETHOS Engage Study Group , 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.', Int J Drug Policy, 105, pp. 103706, http://dx.doi.org/10.1016/j.drugpo.2022.103706

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ project (SToP-C)', Harm Reduction Journal, 18, pp. 46, http://dx.doi.org/10.1186/s12954-021-00494-4

Djordjevic F; Ryan K; Gunn J; Brener L; O’Keefe D; Draper B; Schroeder S; Gold J; Treloar C; Broady T; Dietze P; Hellard M; Pedrana A, 2021, 'Health service utilization and experiences of stigma amongst people who inject drugs in Melbourne, Australia', Journal of Viral Hepatitis, 28, pp. 1738 - 1743, http://dx.doi.org/10.1111/jvh.13612

Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98, http://dx.doi.org/10.1016/j.drugpo.2021.103379

Walker S; Wallace J; Latham N; Saich F; Pedrana A; Hellard M; Treloar C; Marukutira T; Higgs P; Doyle J; Stoové M, 2021, '“It's time!”: A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C', International Journal of Drug Policy, 97, http://dx.doi.org/10.1016/j.drugpo.2021.103280

Cama E; Brener L; Broady T; Hopwood M; Treloar C, 2021, 'Australian health and medical workers’ concerns around providing care to people living with hepatitis B', Health and Social Care in the Community, 29, pp. e431 - e439, http://dx.doi.org/10.1111/hsc.13368

Brener L; Broady T; Cama E; Hopwood M; Byrne J; Treloar C, 2021, 'Positive effects of community attachment on internalised stigma and wellbeing among people who inject drugs', International Journal of Drug Policy, 97, http://dx.doi.org/10.1016/j.drugpo.2021.103323

Rance J; Lafferty L; Treloar C; Loveday S; Dore G; Lloyd A; Grebely J; Butler T; Martin N; Chambers G; Byrne M; Donnelly R; McGrath C; Bowman J; Trevethan L; Grant L; Murrell T; Bath N; Harrod M; Churchill A; Pinnock K; Cairnduff S, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477

Kelly PJ; Beck AK; Deane FP; Larance B; Baker AL; Hides L; Manning V; Shakeshaft A; Neale J; Kelly JF; Oldmeadow C; Searles A; Palazzi K; Lawson K; Treloar C; Gray RM; Argent A; McGlaughlin R, 2021, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in SMART recovery mutual support groups: Stage 1 mixed methods pilot study', Journal of Medical Internet Research, 23, http://dx.doi.org/10.2196/25217

Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J, 2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103421

Broady TR; Brener L; Vuong T; Cama E; Treloar C, 2021, 'Online interventions to reduce stigma towards population groups affected by blood borne viruses in Australia', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103292

Grebely J; Collins AB; Artenie AA; Sutherland R; Meyer JP; Barocas JA; Falade-Nwulia O; Cepeda JA; Cunningham EB; Hajarizadeh B; Lafferty L; Lazarus JV; Bonn M; Marshall AD; Treloar C, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103469

Treloar C; Schroeder S; Lafferty L; Marshall A; Drysdale K; Higgs P; Baldry E; Stoove M; Dietze P, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, pp. 103261, http://dx.doi.org/10.1016/j.drugpo.2021.103261

Treloar C; Hopwood M; Drysdale K; Lea T; Holt M; Dowsett GW; Aggleton P; Bryant J, 2021, 'Stigma as understood by key informants: A social ecological approach to gay and bisexual men's use of crystal methamphetamine for sex', International Journal of Drug Policy, 94, pp. 103229, http://dx.doi.org/10.1016/j.drugpo.2021.103229

Bryant J; Bolt R; Botfield JR; Martin K; Doyle M; Murphy D; Graham S; Newman CE; Bell S; Treloar C; Browne AJ; Aggleton P, 2021, 'Beyond deficit: ‘strengths-based approaches’ in Indigenous health research', Sociology of Health and Illness, 43, pp. 1405 - 1421, http://dx.doi.org/10.1111/1467-9566.13311

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Loveday S; Tamaddoni M; Obeid S; Estivill Mercade G; Martinez M; Donnelly R; Bowman J; Trevethan L; Lagios K; Murrell T; Bath N; Tawil V; Stevens A; Topp L; Churchill A; Pinnock K; Drew S; Harrod M; Smith A; Williams R; Cooper B; Somes K; Burns C; Kaur A; Lobo C; Conroy K; McCredie L; Café C; Anlezark J; Rawlinson W; Yeang M; Wynn M; Willenborg C, 2021, 'Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study', The Lancet Gastroenterology and Hepatology, 6, pp. 533 - 546, http://dx.doi.org/10.1016/S2468-1253(21)00077-7

Valerio H; Alavi M; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Dore G; Grebely J, 2021, 'Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study', Clinical Infectious Diseases, 73, pp. E69 - E78, http://dx.doi.org/10.1093/cid/ciaa571

Stardust Z; Treloar C; Cama E; Kim J, 2021, '‘I Wouldn’t call the cops if i was being bashed to death’: Sex work, whore stigma and the criminal legal system', International Journal for Crime, Justice and Social Democracy, 10, http://dx.doi.org/10.5204/IJCJSD.1894

Lafferty L; Rance J; Dore GJ; Lloyd AR; Treloar C, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277

Drysdale K; Bryant J; Dowsett GW; Lea T; Treloar C; Aggleton P; Holt M, 2021, 'Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex.', Int J Drug Policy, 93, pp. 103163 - 103163, http://dx.doi.org/10.1016/j.drugpo.2021.103163

Madden A; Lancaster K; Ritter A; Treloar C, 2021, 'Making legitimacy: Drug user representation in United Nations drug policy settings', International Journal of Drug Policy, 87, pp. 103014, http://dx.doi.org/10.1016/j.drugpo.2020.103014

Miller K; Treloar C; Lloyd AR, 2021, 'People in prison who inject drugs: who is trusted when it comes to information about hepatitis C?', Addiction Research and Theory, 29, pp. 247 - 254, http://dx.doi.org/10.1080/16066359.2021.1879058

Treloar C; Stardust Z; Cama E; Kim J, 2021, 'Rethinking the relationship between sex work, mental health and stigma: a qualitative study of sex workers in Australia', Social Science and Medicine, 268, http://dx.doi.org/10.1016/j.socscimed.2020.113468

Marshall AD; Hopwood M; Grebely J; Treloar C, 2020, 'Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementation', International Journal of Drug Policy, 86, http://dx.doi.org/10.1016/j.drugpo.2020.102964

Reilly R; Gendera S; Treloar C; Roe Y; Conigrave K; Azzopardi P; Ward J, 2020, 'Identifying risk and protective factors, including culture and identity, for methamphetamine use in Aboriginal and Torres Strait Islander communities: Relevance of the ‘communities that care’ model', Social Science and Medicine, 266, http://dx.doi.org/10.1016/j.socscimed.2020.113451

Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', PLoS ONE, 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106

Broady TR; Brener L; Hopwood M; Cama E; Treloar C; Holt M, 2020, 'HIV stigma by association among Australian gay and bisexual men.', AIDS, 34 Suppl 1, pp. S53 - S62, http://dx.doi.org/10.1097/QAD.0000000000002565

Reilly R; Wand H; McKetin R; Quinn B; Ezard N; Dunlop A; Conigrave K; Treloar C; Roe Y; Gray D; Stephens J; Ward J, 2020, 'Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey', Drug and Alcohol Review, 39, pp. 646 - 655, http://dx.doi.org/10.1111/dar.13085

Dore G; Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Mcmanus H; Butler T; Vickerman P; Martin N; Mchutchison J; Brainard D; Treloar C; Lloyd A, 2020, 'Declining HCV incidence following rapid HCV treatment scale-up in a prison network in Australia: Evidence of treatment as prevention from the SToP-C study', JOURNAL OF HEPATOLOGY, 73, pp. S127 - S127, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000786587000206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M; Treloar C, 2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389

Brener L; Broady T; Cama E; Hopwood M; de Wit JBF; Treloar C, 2020, 'The role of social support in moderating the relationship between HIV centrality, internalised stigma and psychological distress for people living with HIV', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 32, pp. 850 - 857, http://dx.doi.org/10.1080/09540121.2019.1659914

Kelly PJ; Beck AK; Baker AL; Deane FP; Hides L; Manning V; Shakeshaft A; Larance B; Neale J; Kelly J; Oldmeadow C; Searles A; Treloar C; Gray RM; Argent A; McGlaughlin R, 2020, 'Feasibility of a mobile health app for routine outcome monitoring and feedback in mutual support groups coordinated by SMART recovery Australia: Protocol for a pilot study', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/15113

Drysdale K; Bryant J; Holt M; Hopwood M; Dowsett GW; Aggleton P; Lea T; Treloar C, 2020, 'Destabilising the ‘problem’ of chemsex: Diversity in settings, relations and practices revealed in Australian gay and bisexual men's crystal methamphetamine use', International Journal of Drug Policy, 78, pp. 102697, http://dx.doi.org/10.1016/j.drugpo.2020.102697

Broady TR; Brener L; Cama E; Hopwood M; Treloar C, 2020, 'Stigmatising attitudes towards people who inject drugs, and people living with blood borne viruses or sexually transmissible infections in a representative sample of the Australian population', PLoS ONE, 15, pp. e0232218, http://dx.doi.org/10.1371/journal.pone.0232218

Rance J; Lafferty L; Treloar C, 2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225

Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K; Grebely J; Hajarizadeh B; Edwards M, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233

Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693

Hopwood M; Cama E; de Wit J; Treloar C, 2020, 'Stigma, Anxiety, and Depression Among Gay and Bisexual Men in Mixed-Orientation Marriages', Qualitative Health Research, 30, pp. 622 - 633, http://dx.doi.org/10.1177/1049732319862536

Gray R; Kelly PJ; Beck AK; Baker AL; Deane FP; Neale J; Treloar C; Hides L; Manning V; Shakeshaft A; Kelly J; Argent A; McGlaughlin R, 2020, 'A qualitative exploration of SMART Recovery meetings in Australia and the role of a digital platform to support routine outcome monitoring', Addictive Behaviors, 101, http://dx.doi.org/10.1016/j.addbeh.2019.106144

Miller K; Sheaves F; Maher L; Page J; Bridges-Webb I; Treloar C, 2020, '‘C’ the potential: needle and syringe programs as hepatitis C treatment sites', Drugs: Education, Prevention and Policy, 27, pp. 92 - 94, http://dx.doi.org/10.1080/09687637.2019.1583170

Marshall AD; Grebely J; Dore GJ; Treloar C, 2020, 'Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists—The practitioner experience', Drug and Alcohol Dependence, 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107705

Stoové M; Wallace J; Higgs P; Pedrana A; Goutzamanis S; Latham N; Scott N; Treloar C; Crawford S; Doyle J; Hellard M, 2020, 'Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure', International Journal of Drug Policy, 75, http://dx.doi.org/10.1016/j.drugpo.2019.11.004

Marshall AD; Madden A; Treloar C, 2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, 114, pp. 2104 - 2106, http://dx.doi.org/10.1111/add.14698

Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135

Back to profile page